Showcasing Preclinical Proof of Concept of Autophagy-Mediated Protein Degradation Against Aggregated Targets in the Brain

Time: 10:00 am
day: Conference Day One


  • Evaluating AUTOTAC engagement and efficacy in targeted CNS protein degradation
  • Detailing AUTOTAC design to ensure controlled autophagy degradation via P62 targeting
  • Explaining experimental set-up and model systems utilized for testing AUTOTAC therapies